Abstract 4368545: Association Between Blood Pressure and Clinical Events in Peripheral Artery Disease with Small Vessel Disease

R Rohit Nathani (UT Southwestern Medical Center, Dallas, Texas, United States) M Mary Vaughan Sarrazin (University of Iowa, Iowa City, Iowa, United States) P Paul Chan A Ajay Gupta D Dharam Kumbhani (UT Southwestern Medical Center, Dallas, Texas, United States) Q Qiang Li C Cathy Nguyen (UT Southwestern Medical Center, Dallas, Texas, United States) J James de Lemos (UT SOUTHWESTERN MEDICAL CTR, Dallas, Texas, United States) J Joshua Beckman (UT Southwestern, Dallas, Texas, United States) S Saket Girotra (Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.G.).)

Abstract

Background: Intensive blood pressure (BP) control reduces the risk of cardiovascular (CV) events, yet we recently reported a U-shaped association between BP and limb events in peripheral artery disease (PAD). Whether the involvement of pedal arteries or small vessel disease (SVD), which further compromises lower extremity perfusion, modifies this association is unknown. Methods: We analyzed the Peripheral Artery Long-term Survival (PEARLS) cohort, a longitudinal registry of ~100,000 US Veterans with incident PAD between 2015-2020. We defined SVD as a low toe-brachial index (TBI≤0.7) with a normal ankle brachial index (ABI > 0.9) in any limb, suggesting involvement of distal pedal arteries. Cox regression models, with death as a competing risk, were used to evaluate the association between BP as a time-varying exposure and risk of CV (myocardial infarction, stroke) and limb (chronic limb-threatening ischemia, major amputation) events, adjusted for patient demographics, comorbidities, risk factors, and severity of PAD. Analyses were performed separately in patients with and without SVD, and interaction testing was also performed. Results: Among 92,909 patients (mean age 70.5 ± 9.3 years; 97% men; 18.5% Black), 35,496 [38.2%] had SVD. Compared to those without, those with SVD only were older, less likely to be Black or current smokers, but had a higher burden of diabetes and chronic kidney disease (Table 1). Baseline BP differences between groups were small. Over a median follow-up of 3.9 years, SVD was associated with a lower crude incidence rate (per-100 patient years) of CV events (4.1 vs. 5.0) and limb events (4.4 vs. 5.6), compared to patients without SVD. In both strata, there was a graded positive association between increasing systolic BP risk of CV events (P for interaction=0.54; Figure 1). Conversely, systolic BP displayed a U-shaped association with limb events, with increased hazard in both low and high BP. This pattern was more pronounced in patients with SVD (P for interaction <0.01; Figure 1). Findings for diastolic blood pressure were similar (Figure 2). Conclusion: In PAD, higher BP is associated with a higher risk of CV events, whereas the association with limb events was U-shaped. The increased hazard of limb events at both low and high BP is accentuated in patients with SVD. These findings highlight the need for individualized BP targets in PAD, particularly when SVD is present.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (10)

R

Rohit Nathani

UT Southwestern Medical Center, Dallas, Texas, United States

M

Mary Vaughan Sarrazin

University of Iowa, Iowa City, Iowa, United States

P

Paul Chan

A

Ajay Gupta

D

Dharam Kumbhani

UT Southwestern Medical Center, Dallas, Texas, United States

Q

Qiang Li

C

Cathy Nguyen

UT Southwestern Medical Center, Dallas, Texas, United States

J

James de Lemos

UT SOUTHWESTERN MEDICAL CTR, Dallas, Texas, United States

J

Joshua Beckman

UT Southwestern, Dallas, Texas, United States

S

Saket Girotra

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.G.).